Hints and tips:
Related Topics
...Mallinckrodt emerged from a previous bankruptcy filing just a year ago in a deal that was set to pay the opioid trust $1.725bn in total payments through 2027....
...A little over a year ago, victims of the opioid manufacturer Mallinckrodt were in line for a $1.7bn payout through to 2028....
...No such shell game for Mallinckrodt, a producer of opioids that filed for bankruptcy in 2020....
...Mallinckrodt did not disclose if it would make a $200mn payment owed on Friday to the trust....
...On Thursday, Mallinckrodt said it would skip a June interest payment on about $1bn of bonds....
...The shadows deepened even further for me with the tale of Mallinckrodt....
...paid out claims to parties once allegedly harmed by opioids manufactured and marketed by Mallinckrodt....
...Mallinckrodt has suffered no such difficulties but its travails still demonstrate that business execution matters, too....
...Like peers Purdue Pharma and Mallinckrodt, Endo believes the power of the bankruptcy process to funnel opioid litigation into a single, binding forum is the cleanest way to resolve its liability....
...But Mr Bischoff said it was wrong to categorise Mallinckrodt solely as a penny pincher....
...In addition to J&J, the complaint named Purdue Pharma and the members of the Sackler family that own it, Mallinckrodt, Endo, and Teva among others....
...Mallinckrodt had another legal headache. Its leading product Acthar Gel, a treatment for multiple sclerosis, faced allegations of price gouging....
...Philip Mallinckrodt, another member of the Schroders family, will quit the board next month and be replaced by his sister, Claire Fitzalan Howard....
...George Mallinckrodt: Holder of high office Tributes to the late George Mallinckrodt, former executive chair of Schroders, recall a summons to Buckingham Palace to explain why the firm had replaced the Queen...
...There is one interesting sweetener Mallinckrodt has thrown into the pot....
...Moreover, it collected millions of dollars designing and implementing marketing campaigns for three other opioid manufacturers — Johnson & Johnson, Endo Pharmaceuticals and Mallinckrodt — the lawsuits found...
...Philip Mallinckrodt, 57, will retire as a director at the end of April after the annual shareholder meeting....
...Philip Mallinckrodt, nephew of recently deceased patriarch Bruno Schroder, last week announced he would retire from the board — to be replaced by his older sister Claire....
...The news hit the shares of other companies embroiled in litigation such as Teva, Endo and Mallinckrodt. Some investors expect further falls....
...Pharmaceutical companies Endo International settled both cases for $10m, Johnson & Johnson for $20m and Mallinckrodt for $30m....
...Endo International, which settled these cases for about $10m, was down 2.4 per cent to $4.76, and Mallinckrodt, which settled the two cases for about $30m, fell 3 per cent to $2.66....
...Mallinckrodt, a drug distributor, slumped 14 per cent to $3.63, but it was partly dragged down in response to an appeals court ruling in an intellectual property case that was seen as negative to the stock...
... An R&D update accelerating/re-prioritising its pipeline assets based on the influx of cash from the AstraZeneca deal (in addition to that received in the Mallinckrodt deal)....
...Mallinckrodt also took options to sign similarly structured deals over two drugs in Silence development pipeline....
...The £7.2bn company is 47.9 per cent-owned by the Schroders and the Mallinckrodts, two wings of the family....
International Edition